Global Infertility Testing Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Infertility Testing Market By Type (Female Infertility Testing, Male Infertility Testing), Test Kits (Follicular Stimulating Hormone (FSH) Urine Test Kits, Luteinizing Hormone (LH) Urine Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits, Other Test Kits), Prescription Mode (Prescription Based, Over The Counter (OTC) Based), Distribution Channel (Hospitals Pharmacies, Online Pharmacies, Pharmacies & Drug Stores), End Users (Fertility Centers, Hospitals and Clinics, Research Institutes, Cryobanks), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Infertility Testing Market

Global infertility testing market is registering a substantial CAGR of 7.30% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to advances and innovations in healthcare where there has been the availability of fine-tuned fertility testing and treatment is contributing to the market growth.

Market Definition: Global Infertility Testing Market

Infertility testing is tests that are done to figure out why a woman cannot become pregnant. The tests also helps to determine whether the problem is with the man, the woman, or both. The testing and evaluation of infertility are expensive and their procedures can sometimes be little uncomfortable. There are various male infertility tests which include DNA fragmentation, sperm penetration assay and oxidative stress analysis and female infertility tests which include ovulation testing, laparoscopy, ovarian reserve testing and hormone testing. Infertility testing is done in the fertility centers, research institutes and hospitals and clinics.

Market Drivers

  • The surge in infertility and awareness for its treatment is driving the market growth
  • The medical tourism for fertility treatments has boosted the market growth
  • The increase in the rate of gynecological disorders of fueling the market growth
  • The technical advancements an innovations in the field of testing products are propelling the market growth
  • The surging effectiveness of treatments is driving the market growth

Market Restraints

  • The regulation issues prevailing in the countries globally are hindering the market growth
  • The rise in cost for the treatment and testing is hampering the market growth
  • The testing kits have accuracy issues which restraints the market growth

Segmentation: Global Infertility Testing Market

By Type

  • Female Infertility Testing

    • Ovulation Testing
    • Hysterosalpingography
    • Laparoscopy
    • Transvaginal Ultrasound
    • Ovarian Reserve Testing
    • Hormone Testing
    • Others

  • Male Infertility Testing

    • DNA Fragmentation
    • Oxidative Stress Analysis
    • Sperm Penetration Assay
    • Computer Aided Semen Analysis
    • Sperm Agglutination Assay
    • Microscopic Examination
    • Others

By Test Kits

  • Follicular Stimulating Hormone (FSH) Urine Test Kits
  • Luteinizing Hormone (LH) Urine Test Kits
  • Human Chorionic Gonadotropin (HCG) Hormone Blood Test Kits
  • Other Test Kits

By Prescription Mode

  • Prescription Based
  • Over The Counter (OTC) Based

By Distribution Channel

  • Hospitals Pharmacies
  • Online Pharmacies
  • Pharmacies & Drug Stores

BY End Users

  • Fertility Centers
  • Hospitals and Clinics
  • Research Institutes
  • Cryobanks

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In October 2018, Predictive Technology Group, Inc. had launched endometriosis risk test ARTguide. It is a non-invasive diagnostic test to find the genetic and endometriosis causes of infertility. It will help couples who have faced challenge in having babies by transforming the lucrative assisted reproductive technology market. This launch had expanded the portfolio of the company and expanded its market share in infertility testing.
  • In July 2018, Merck KGaA had launched an online platform Fertility.com which will enable healthcare professionals and doctors to access the latest researches and scientific information as well as enabling the patients who are undergoing treatment related to fertility treatment. This launch had expanded the user base for the company and positioned it as a market leader.

Competitive Analysis:

Global infertility testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of infertility testing market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the global infertility testing market are Halotech DNA, Procter & Gamble, Andrology Solutions, SA Scientific, bioMérieux SA, Abbott, Quidel Corporation, Atlas Medical Uk, Babystart Ltd., SCSA Diagnostics, Gem Medic Technology Co. Ltd., Merck KGaA, bioZhena Corporation, Vitrolife, Progyny Inc., Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Thermo Fisher Scientific, Siemens, Stryker, Metropolis India, CENTOGENE AG, Mayo Foundation for Medical Education and Research (MFMER) and Dr Lal PathLabs among others.

Research Methodology: Global Infertility Testing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global infertility testing market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

LIST OF TABLE GLOBAL INFERTILITY TESTING MARKET

TABLE 1 GLOBAL INFERTILITY TESTING MARKET, BY TYPE, 2015– 2024 (USD MILLION) TABLE 2 GLOBAL FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 3 GLOBAL FEMALE INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 4 GLOBAL MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 5 GLOBAL MALE INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 6 GLOBAL INFERTILITY TESTING MARKET, BY TEST KITS, 2015– 2024 (USD MILLION) TABLE 7 GLOBAL FOLLICULAR STIMULATING HORMONE INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 8 GLOBAL LUTEINIZING HORMONE URINE TEST KITS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 9 GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) HORMONE BLOOD TEST KITS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 10 GLOBAL OTHER TEST KITS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 11 GLOBAL INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015– 2024 (USD MILLION) TABLE 12 GLOBAL PRESCRIPTION BASED INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 13 GLOBAL OVER THE COUNTER (OTC) BASED INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 14 GLOBAL INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) TABLE 15 GLOBAL HOSPITALS PHARMACIES INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 16 GLOBAL ONLINE PHARMACIES INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 17 GLOBAL PHARMACIES & DRUG STORES INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 18 GLOBAL INFERTILITY TESTING MARKET, BY END USER, 2015– 2024 (USD MILLION) TABLE 19 GLOBAL FERTILITY CENTERS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 20 GLOBAL HOSPITALS AND CLINICS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 21 GLOBAL RESEARCH INSTITUTES INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 22 GLOBAL CRYOBANKS INFERTILITY TESTING MARKET, BY REGION, 2015 – 2024 (USD MILLION) TABLE 23 GLOBAL INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 27 NORTH AMERICA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 28 NORTH AMERICA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 29 NORTH AMERICA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 30 NORTH AMERICA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 31 NORTH AMERICA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 32 U.S. INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 33 U.S. FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 34 U.S. MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 35 U.S. INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 36 U.S. INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 37 U.S. INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 38 U.S. INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 39 CANADA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 40 CANADA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 41 CANADA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 42 CANADA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 43 CANADA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 44 CANADA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 45 CANADA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 46 MEXICO INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 47 MEXICO FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 48 MEXICO MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 49 MEXICO INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 50 MEXICO INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 51 MEXICO INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 52 MEXICO INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 53 EUROPE INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 54 EUROPE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 55 EUROPE FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 56 EUROPE MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 57 EUROPE INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 58 EUROPE INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 59 EUROPE INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 60 EUROPE INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 61 GERMANY INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 62 GERMANY FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 63 GERMANY MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 64 GERMANY INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 65 GERMANY INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, USD MILLION (2015 – 2024) TABLE 66 GERMANY INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 67 GERMANY INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 68 FRANCE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 69 FRANCE FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 70 FRANCE MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 71 FRANCE INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 72 FRANCE INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 73 FRANCE INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 74 FRANCE INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 75 U.K. INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 76 U.K. FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 77 U.K. MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 78 U.K. INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 79 U.K. INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 80 U.K. INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 81 U.K. INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 82 ITALY INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 83 ITALY FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 84 ITALY MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 85 ITALY INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 86 ITALY INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 87 ITALY INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 88 ITALY INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 89 SPAIN INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 90 SPAIN FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 91 SPAIN MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 92 SPAIN INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 93 SPAIN INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 94 SPAIN INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 95 SPAIN INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 96 RUSSIA INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 97 RUSSIA FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 98 RUSSIA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 99 RUSSIA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 100 RUSSIA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 101 RUSSIA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 102 RUSSIA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 103 TURKEY INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 104 TURKEY FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 105 TURKEY MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 106 TURKEY INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 107 TURKEY INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 108 TURKEY INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 109 TURKEY INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 110 BELGIUM INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 111 BELGIUM FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 112 BELGIUM MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 113 BELGIUM INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 114 BELGIUM INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 115 BELGIUM INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 116 BELGIUM INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 117 NETHERLANDS INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 118 NETHERLANDS FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 119 NETHERLANDS MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 120 NETHERLANDS INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 121 NETHERLANDS INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 122 NETHERLANDS INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 123 NETHERLANDS INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 124 SWITZERLAND INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 125 SWITZERLAND FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 126 SWITZERLAND MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 127 SWITZERLAND INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 128 SWITZERLAND INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 129 SWITZERLAND INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 130 SWITZERLAND INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 131 REST OF EUROPE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 132 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 133 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 134 ASIA-PACIFIC FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 135 ASIA-PACIFIC MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 136 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 137 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 138 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 139 ASIA-PACIFIC INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 140 JAPAN INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 141 JAPAN FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 142 JAPAN MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 143 JAPAN INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 144 JAPAN INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 145 JAPAN INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 146 JAPAN INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 147 CHINA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 148 CHINA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 149 CHINA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 150 CHINA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 151 CHINA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 152 CHINA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 153 CHINA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 154 INDIA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 155 INDIA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 156 INDIA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 157 INDIA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 158 INDIA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 159 INDIA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 160 INDIA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 161 SOUTH KOREA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 162 SOUTH KOREA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 163 SOUTH KOREA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 164 SOUTH KOREA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 165 SOUTH KOREA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 166 SOUTH KOREA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 167 SOUTH KOREA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 168 AUSTRALIA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 169 AUSTRALIA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 170 AUSTRALIA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 171 AUSTRALIA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 172 AUSTRALIA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 173 AUSTRALIA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 174 AUSTRALIA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 175 SINGAPORE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 176 SINGAPORE FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 177 SINGAPORE MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 178 SINGAPORE INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 179 SINGAPORE INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 180 SINGAPORE INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 181 SINGAPORE INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 182 THAILAND INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 183 THAILAND FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 184 THAILAND MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 185 THAILAND INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 186 THAILAND INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 187 THAILAND INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 188 THAILAND INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 189 MALAYSIA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 190 MALAYSIA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 191 MALAYSIA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 192 MALAYSIA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 193 MALAYSIA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 194 MALAYSIA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 195 MALAYSIA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 196 INDONESIA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 197 INDONESIA FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 198 INDONESIA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 199 INDONESIA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 200 INDONESIA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 201 INDONESIA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 202 INDONESIA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 203 PHILIPPINES INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 204 PHILIPPINES FEMALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 205 PHILIPPINES MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 206 PHILIPPINES INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 207 PHILIPPINES INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 208 PHILIPPINES INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 209 PHILIPPINES INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 210 REST OF ASIA-PACIFIC INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 211 SOUTH AMERICA INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 212 SOUTH AMERICA INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 213 SOUTH AMERICA FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 214 SOUTH AMERICA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 215 SOUTH AMERICA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 216 SOUTH AMERICA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 217 SOUTH AMERICA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL,2015 – 2024 (USD MILLION) TABLE 218 SOUTH AMERICA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 219 BRAZIL INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 220 BRAZIL FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 221 BRAZIL MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 222 BRAZIL INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 223 BRAZIL INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 224 BRAZIL INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 225 BRAZIL INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 226 REST OF SOUTH AMERICA INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 227 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 228 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 229 MIDDLE EAST AND AFRICA FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 230 MIDDLE EAST AND AFRICA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 231 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 232 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 233 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 234 MIDDLE EAST AND AFRICA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 235 SOUTH AFRICA INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 236 SOUTH AFRICA FEMALE INFERTILITY TESTING MARKET, BY TYPE 2015 – 2024 (USD MILLION) TABLE 237 SOUTH AFRICA MALE INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION) TABLE 238 SOUTH AFRICA INFERTILITY TESTING MARKET, BY TEST KITS, 2015 – 2024 (USD MILLION) TABLE 239 SOUTH AFRICA INFERTILITY TESTING MARKET, BY PRESCRIPTION MODE, 2015 – 2024 (USD MILLION) TABLE 240 SOUTH AFRICA INFERTILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) TABLE 241 SOUTH AFRICA INFERTILITY TESTING MARKET, BY END USER, 2015 – 2024 (USD MILLION) TABLE 242 REST OF MIDDLE EAST & AFRICA INFERTILITY TESTING MARKET, BY TYPE, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19